Right Coronary Artery Occlusion: Disease Bioinformatics
A Right Coronary Artery Occlusion is when the right artery in the heart is blocked by a clot. The right coronary artery is the blood vessel in the heart that supplies the right side of the heart with oxygenated blood. The symptoms of a Right Coronary Artery Occlusion include chest pain, shortness of breath, and fatigue. A Right Coronary Artery Occlusion is caused by plaque buildup on the inner lining of the artery or by a temporary muscle spasm of the heart. Treatments for a Right Coronary Artery Occlusion include medications to lower the heart rate, medications to relax the artery wall, and angioplasty to expand the artery. A Right Coronary Artery Occlusion can lead to a heart attack which can have lasting effects on the body, but changes in diet and smoking habits can improve the future outlook.
Right Coronary Artery Occlusion Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Right Coronary Artery Occlusion below!
For more information on how to use Laverne, please read the How to Guide.
We have 592 products for the study of Right Coronary Artery Occlusion that can be applied to Flow Cytometry, Chromatin Immunoprecipitation, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Right Coronary Artery Occlusion is also known as Right Coronary Artery Obstruction.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.